In this video, Dr. Viveka Kumar, Senior Director - Cath Lab, Max Super Speciality Hospital, Saket, will discuss the role of prasugrel in acute MI. Prasugrel is a very potent drug in acute MI. Any patient after his angiography is done and has to undergo primary PCI, then prasugrel is given to such patients and the stent patency and thrombosis rate is controlled. He will also explain the conditions when the prasugrel is not recommended and which other alternative treatment is given.
Dr Viveka Kumar is a Senior Consultant Interventional Cardiologist and Director of the Cath Lab at Max Super Speciality Hospital in Saket, New Delhi. He completed his MBBS and MD (Medicine) from IMS (BHU), Varanasi and later obtained the DM (Cardiology) postdoc, superspeciality degree through GSVM Medical College, Kanpur. Has extensive experience in the field of Cardiac interventions and Electrophysiology. Specializes in complex angioplasties including multivessel, bifurication and left main angioplasties with Rota Ablation, FFR, IVUS, IABP, IMPELLA devices. Has done more than 7500 angioplasties and 2500 balloon valvotomies with good outcomes.